Abstract
This follow-up study of the CORIMUNO-TOCI-1 randomized clinical trial examines the association between survival and C-reactive protein levels in patients hospitalized with COVID-19 who were treated with tocilizumab.
All Keywords
【초록키워드】 randomized clinical trial, Tocilizumab, C-reactive protein, survival, association, follow-up study, treated, patients hospitalized, with COVID-19, 【제목키워드】 clinical,
【초록키워드】 randomized clinical trial, Tocilizumab, C-reactive protein, survival, association, follow-up study, treated, patients hospitalized, with COVID-19, 【제목키워드】 clinical,
{{{ 추상적인 }}}
CORIMUNO-TOCI-1 무작위 임상 시험의 이 후속 연구는 토실리주맙으로 치료를 받은 COVID-19로 입원한 환자의 생존과 C 반응성 단백질 수준 사이의 연관성을 조사합니다.